Hasil menunjukkan data bersifat homogen

- Valsartan memiliki energi yang lebih rendah dibanding yang lain (berbeda signifikan)
- Losartan energi lebih rendah dibanding yang lain kecuali valsartan (berbeda
signifikan)
- Kuersetin lebih rendah dibanding epikatekin, genistein dan hesperetin, sedangkan
kersetin dibanding luteolin lebih besar kuersetin, (tidak berbeda signifikan terhadap
genistein dan luteolin)
- Epikatekin lebih rendah dibanding hesperetin, tidak berbeda signifikan terhadap
hesperetin
- Genistein lebih besar dibanding luteolin dan tidak berbeda signifikan
- Hesperetin lebih besar dibanding yang lain
 Valsartan
 Losartan
 luteolin
 kuersetin
 Genistein
 Epikatekin
 Hesperetin

Descriptives
afinitas

95% Confidence
Std. Std. Interval for Mean Minimu
N Mean Maximum
Deviation Error Lower Upper m
Bound Bound
valsartan 9 -8,800 ,2000 ,0667 -8,954 -8,646 -9,2 -8,6
losartan 9 -8,456 ,1810 ,0603 -8,595 -8,316 -8,7 -8,2
kuersetin 9 -7,789 ,4076 ,1359 -8,102 -7,476 -8,3 -7,2
epikateki
9 -7,211 ,3756 ,1252 -7,500 -6,922 -7,8 -6,7
n
genistein 9 -7,711 ,2713 ,0904 -7,920 -7,503 -8,3 -7,5
luteolin 9 -7,922 ,2774 ,0925 -8,135 -7,709 -8,3 -7,5
hespereti
9 -7,000 ,3775 ,1258 -7,290 -6,710 -7,6 -6,7
n
Total 63 -7,841 ,6627 ,0835 -8,008 -7,674 -9,2 -6,7

Tests of Normality
Kolmogorov-Smirnova Shapiro-Wilk
Ligan Statistic df Sig. Statistic df Sig.
*
afinitas valsartan ,197 9 ,200 ,874 9 ,137
losartan ,264 9 ,071 ,891 9 ,207
kuersetin ,177 9 ,200* ,916 9 ,363
*
epikatekin ,130 9 ,200 ,967 9 ,869
genistein ,294 9 ,024 ,790 9 ,016
 luteolin ,184 9 ,200* ,948 9 ,665
hesperetin ,257 9 ,087 ,773 9 ,010

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction

Test of Homogeneity of Variances

afinitas
Levene
Statistic df1 df2 Sig.
2,253 6 56 ,051

Multiple Comparisons
Dependent Variable: afinitas
LSD
Mean 95% Confidence Interval
Difference Std. Lower Upper
(I) Ligan (J) Ligan (I-J) Error Sig. Bound Bound
*
valsartan losartan -,3444 ,1462 ,022 -,637 -,052
kuersetin -1,0111* ,1462 ,000 -1,304 -,718
*
epikatekin -1,5889 ,1462 ,000 -1,882 -1,296
*
genistein -1,0889 ,1462 ,000 -1,382 -,796
*
luteolin -,8778 ,1462 ,000 -1,171 -,585
*
hesperetin -1,8000 ,1462 ,000 -2,093 -1,507
*
losartan valsartan ,3444 ,1462 ,022 ,052 ,637
kuersetin -,6667* ,1462 ,000 -,959 -,374
*
epikatekin -1,2444 ,1462 ,000 -1,537 -,952
*
genistein -,7444 ,1462 ,000 -1,037 -,452
*
luteolin -,5333 ,1462 ,001 -,826 -,241
*
hesperetin -1,4556 ,1462 ,000 -1,748 -1,163
kuersetin valsartan 1,0111* ,1462 ,000 ,718 1,304
*
losartan ,6667 ,1462 ,000 ,374 ,959
*
epikatekin -,5778 ,1462 ,000 -,871 -,285
genistein -,0778 ,1462 ,597 -,371 ,215
luteolin ,1333 ,1462 ,366 -,159 ,426
*
hesperetin -,7889 ,1462 ,000 -1,082 -,496
epikatekin valsartan 1,5889* ,1462 ,000 1,296 1,882
*
losartan 1,2444 ,1462 ,000 ,952 1,537
*
kuersetin ,5778 ,1462 ,000 ,285 ,871
*
genistein ,5000 ,1462 ,001 ,207 ,793
*
luteolin ,7111 ,1462 ,000 ,418 1,004
hesperetin -,2111 ,1462 ,154 -,504 ,082
genistein valsartan 1,0889* ,1462 ,000 ,796 1,382
*
losartan ,7444 ,1462 ,000 ,452 1,037
 kuersetin ,0778 ,1462 ,597 -,215 ,371
epikatekin -,5000* ,1462 ,001 -,793 -,207
luteolin ,2111 ,1462 ,154 -,082 ,504
hesperetin -,7111* ,1462 ,000 -1,004 -,418
luteolin valsartan ,8778* ,1462 ,000 ,585 1,171
losartan ,5333* ,1462 ,001 ,241 ,826
kuersetin -,1333 ,1462 ,366 -,426 ,159
epikatekin -,7111* ,1462 ,000 -1,004 -,418
genistein -,2111 ,1462 ,154 -,504 ,082
hesperetin -,9222* ,1462 ,000 -1,215 -,629
hesperetin valsartan 1,8000* ,1462 ,000 1,507 2,093
losartan 1,4556* ,1462 ,000 1,163 1,748
kuersetin ,7889* ,1462 ,000 ,496 1,082
epikatekin ,2111 ,1462 ,154 -,082 ,504
genistein ,7111* ,1462 ,000 ,418 1,004
luteolin ,9222* ,1462 ,000 ,629 1,215

*. The mean difference is significant at the 0.05 level.